1

Recombinant C1 inhibitor in the prevention of severe COVID-19: a randomized, open-label, multi-center phase IIa trial

fxlahndkzgo9s1
BackgroundConestat alfa (ConA). a recombinant human C1 inhibitor. may prevent thromboinflammation. MethodsWe conducted a randomized. https://rbdoutlet.shop/product-category/little-kids-shoes/
Report this page

Comments

    HTML is allowed

Who Upvoted this Story